ArticleBlood advances2023

JAK2 V617F mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes.

Maryam Rafati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.